ER stress and the expression of factors supporting the re-translocation and degradation of clusterin are more expressed in environments associated with metabolic syndrome (e.g., hyperlipidaemia, glucose-intolerance, and obesity) than in psoriasis. The gene discussed is CLU; the disease is metabolic syndrome.